Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (

Research output: Contribution to journalArticle

Abstract

Background: There is limited knowledge about prognosis of selected breast cancer subtypes among very young women. Patients and methods: We explored patterns of recurrence by age according to four immunohistochemically defined tumor subtypes: Luminal A and Luminal B (estrogen receptor positive and/or progesterone receptor positive and either human epidermal growth factor receptor 2 (HER2) positive and/or high Ki-67), HER2-positive (and) endocrine receptor absent and Triple Negative, in 2970 premenopausal patients with pT1-3, pN0-3 and M0 breast cancer. Results: Patients

Original languageEnglish
Pages (from-to)1974-1981
Number of pages8
JournalAnnals of Oncology
Volume21
Issue number10
DOIs
Publication statusPublished - Mar 23 2010

Fingerprint

Breast Neoplasms
Progesterone Receptors
Estrogen Receptors
Therapeutics
Recurrence
Neoplasms
human ERBB2 protein
Breast Cancer 3

Keywords

  • Adjuvant therapy
  • Breast cancer
  • Prognostic features
  • Very young women

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

@article{f29b4c9900b84777a5f2db44e41353f6,
title = "Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (",
abstract = "Background: There is limited knowledge about prognosis of selected breast cancer subtypes among very young women. Patients and methods: We explored patterns of recurrence by age according to four immunohistochemically defined tumor subtypes: Luminal A and Luminal B (estrogen receptor positive and/or progesterone receptor positive and either human epidermal growth factor receptor 2 (HER2) positive and/or high Ki-67), HER2-positive (and) endocrine receptor absent and Triple Negative, in 2970 premenopausal patients with pT1-3, pN0-3 and M0 breast cancer. Results: Patients",
keywords = "Adjuvant therapy, Breast cancer, Prognostic features, Very young women",
author = "G. Cancello and P. Maisonneuve and N. Rotmensz and G. Viale and Mastropasqua, {M. G.} and G. Pruneri and P. Veronesi and R. Torrisi and E. Montagna and A. Luini and M. Intra and O. Gentilini and R. Ghisini and A. Goldhirsch and M. Colleoni",
year = "2010",
month = "3",
day = "23",
doi = "10.1093/annonc/mdq072",
language = "English",
volume = "21",
pages = "1974--1981",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "NLM (Medline)",
number = "10",

}

TY - JOUR

T1 - Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (

AU - Cancello, G.

AU - Maisonneuve, P.

AU - Rotmensz, N.

AU - Viale, G.

AU - Mastropasqua, M. G.

AU - Pruneri, G.

AU - Veronesi, P.

AU - Torrisi, R.

AU - Montagna, E.

AU - Luini, A.

AU - Intra, M.

AU - Gentilini, O.

AU - Ghisini, R.

AU - Goldhirsch, A.

AU - Colleoni, M.

PY - 2010/3/23

Y1 - 2010/3/23

N2 - Background: There is limited knowledge about prognosis of selected breast cancer subtypes among very young women. Patients and methods: We explored patterns of recurrence by age according to four immunohistochemically defined tumor subtypes: Luminal A and Luminal B (estrogen receptor positive and/or progesterone receptor positive and either human epidermal growth factor receptor 2 (HER2) positive and/or high Ki-67), HER2-positive (and) endocrine receptor absent and Triple Negative, in 2970 premenopausal patients with pT1-3, pN0-3 and M0 breast cancer. Results: Patients

AB - Background: There is limited knowledge about prognosis of selected breast cancer subtypes among very young women. Patients and methods: We explored patterns of recurrence by age according to four immunohistochemically defined tumor subtypes: Luminal A and Luminal B (estrogen receptor positive and/or progesterone receptor positive and either human epidermal growth factor receptor 2 (HER2) positive and/or high Ki-67), HER2-positive (and) endocrine receptor absent and Triple Negative, in 2970 premenopausal patients with pT1-3, pN0-3 and M0 breast cancer. Results: Patients

KW - Adjuvant therapy

KW - Breast cancer

KW - Prognostic features

KW - Very young women

UR - http://www.scopus.com/inward/record.url?scp=77957110787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957110787&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdq072

DO - 10.1093/annonc/mdq072

M3 - Article

C2 - 20332136

AN - SCOPUS:77957110787

VL - 21

SP - 1974

EP - 1981

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 10

ER -